Opinion|Videos|July 8, 2024
Optimizing Management of Atopic Dermatitis and Alopecia Areata: From First-Line to Second-Line Treatments and Safety Protocols
Author(s)Robert Bruce Posnick, MD
Robert Bruce Posnick, MD, examines a case of a 55-year-old female patient with a 50-year history of atopic dermatitis, comorbid asthma, and severe alopecia areata, presenting with recurrent patches throughout her body, predominantly affecting her face, hands, trunk, arms, legs, and eyelids.
Advertisement
- What is your impression of this case? What challenges does this case present with, if any?
- What co-morbidities do you typically see with Atopic Dermatitis?
- Given her history, would you treat systemically? If so, oral JAK or injectable biologic?
- Would you consider a topical JAK, ie ruxolitinib? If so, any concern using topical JAK in combo with systemic therapy, if so which ones?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA
2
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
3
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
4
Introducing Dermatology Times NP/PA Connect
5